High-conductance calcium-activated potassium channels: validated targets for smooth muscle relaxants?

被引:14
作者
Garcia, Maria L. [1 ]
Shen, Dong-Ming [1 ]
Kaczorowski, Gregory J. [1 ]
机构
[1] Merck Res Labs, Dept Ion Channels, Rahway, NJ 07065 USA
关键词
erectile dysfunction; Maxi-K channel openers; smooth muscle relaxation; urinary incontinence; vasorelaxation;
D O I
10.1517/13543776.17.7.831
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
High-conductance, calcium-activated potassium (Maxi-K) channels represent a group of proteins with diverse physiologic functions. Although the role of Maxi-K channels in the CNS is complex and still an area of active academic research, there appears to be better agreement concerning the contribution of these channels to the regulation of smooth muscle tone and, thus the expectations remain high for Maxi-K channel openers having use in the treatment of hypertension, overactive bladder, asthma or erectile dysfunction. Despite this consensus view, at the present time, there is only one compound that targets Maxi-K channels in clinical development for overactive bladder conditions. In the present review, the latest developments in the identification of potent and selective Maxi-K channel openers and their utility in the treatment of smooth muscle disorders will be discussed.
引用
收藏
页码:831 / 842
页数:12
相关论文
共 74 条
[1]  
4SC AG, 2005, Patent No. 20050070570
[2]  
AM HOME PRODUCTS WYE, 2001, Patent No. 6288099
[3]   Modulation of the molecular composition of large conductance, Ca2+activated K+ channels in vascular smooth muscle during hypertension [J].
Amberg, GC ;
Bonev, AD ;
Rossow, CF ;
Nelson, MT ;
Santana, LF .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) :717-724
[4]   Downregulation of the BK channel β1 subunit in genetic hypertension [J].
Amberg, GC ;
Santana, LF .
CIRCULATION RESEARCH, 2003, 93 (10) :965-971
[5]   Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes [J].
Angelico, P ;
Guarneri, L ;
Velasco, C ;
Cova, R ;
Leonardi, A ;
Clarke, DE ;
Testa, R .
BJU INTERNATIONAL, 2006, 97 (04) :837-846
[6]   An overview of potassium channel activators for the treatment of overactive bladder: a survey of new structures 2000-2005 [J].
Argentieri, Thomas M. ;
Butera, John A. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (05) :573-585
[7]   Maxi-K channels contribute to urinary potassium excretion in the ROMK- deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet [J].
Bailey, M. A. ;
Cantone, A. ;
Yan, Q. ;
MacGregor, G. G. ;
Leng, Q. ;
Amorim, J. B. O. ;
Wang, T. ;
Hebert, S. C. ;
Giebisch, G. ;
Malnic, G. .
KIDNEY INTERNATIONAL, 2006, 70 (01) :51-59
[8]   Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V [J].
Biagi, G ;
Giorgi, I ;
Livi, O ;
Nardi, A ;
Calderone, V ;
Martelli, A ;
Martinotti, E ;
Salerni, OL .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (06) :491-498
[9]   BK channel β4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures [J].
Brenner, R ;
Chen, QH ;
Vilaythong, A ;
Toney, GM ;
Noebels, JL ;
Aldrich, RW .
NATURE NEUROSCIENCE, 2005, 8 (12) :1752-1759
[10]   Vasoregulation by the β1 subunit of the calcium-activated potassium channel [J].
Brenner, R ;
Peréz, GJ ;
Bonev, AD ;
Eckman, DM ;
Kosek, JC ;
Wiler, SW ;
Patterson, AJ ;
Nelson, MT ;
Aldrich, RW .
NATURE, 2000, 407 (6806) :870-876